Position in COGT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$10,316,799
+$5,410,518 QoQ
Shares Held
266,584
+109.1% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 321 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. COGT ranks #42 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in COGT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,316,799 | 266,584 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $4,906,281 | 127,469 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $3,876,226 | 109,128 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,380,383 | 96,127 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $414,500 | 57,730 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $424,672 | 70,897 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $618,266 | 79,265 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $1,758,865 | 162,858 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $2,010,049 | 238,440 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $1,605,582 | 238,926 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $220,117 | 37,435 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $370,830 | 38,034 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $342,507 | 28,928 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $473,670 | 43,899 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $407,732 | 35,271 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $400,079 | 26,815 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $190,231 | 21,090 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $151,125 | 20,177 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $193,693 | 22,575 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $179,746 | 21,373 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $178,906 | 22,060 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||